Home Health Care News April 24, 2024
While waiting for UnitedHealth Group’s (NYSE: UNH) purchase of it to finalize, Amedisys Inc. (Nasdaq: AMED) continues to grow its home health segment – primarily through non-Medicare revenue – and its higher-acuity care segment.
The company reported its first-quarter earnings late Wednesday, which showed a 10% increase in total same store admissions in home health care and a 23% year-over-year jump in higher-acuity care admissions.
Hospice admissions and revenue, meanwhile, dipped slightly year over year.
Overall, the company brought in $571.4 million in the quarter, a 2.7% increase compared to the $556.4 billion it brought in over the same time period last year. Home health revenue increased from $343.3 million to $360...
Today's Sponsors
Today's Sponsor